CD163L1
Basic information
Region (hg38): 12:7346685-7479897
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD163L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 10 | ||||
missense | 64 | 11 | 76 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 64 | 21 | 1 |
Variants in CD163L1
This is a list of pathogenic ClinVar variants found in the CD163L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-7357451-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
12-7367239-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
12-7367263-C-G | not specified | Uncertain significance (Jul 26, 2023) | ||
12-7368939-A-G | Likely benign (Feb 01, 2024) | |||
12-7368945-T-C | not specified | Uncertain significance (Jan 02, 2024) | ||
12-7369385-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
12-7369417-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
12-7369456-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
12-7369575-G-T | Benign (May 16, 2018) | |||
12-7369593-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
12-7369606-C-A | not specified | Uncertain significance (Dec 01, 2022) | ||
12-7369636-C-T | not specified | Uncertain significance (Aug 29, 2023) | ||
12-7369645-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
12-7373393-T-C | not specified | Uncertain significance (Jul 14, 2022) | ||
12-7373400-A-C | not specified | Uncertain significance (Apr 06, 2022) | ||
12-7373406-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
12-7373467-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
12-7373524-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
12-7373526-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
12-7373530-T-C | not specified | Likely benign (Aug 05, 2024) | ||
12-7373551-C-T | not specified | Uncertain significance (May 26, 2024) | ||
12-7374458-T-C | Likely benign (Nov 01, 2022) | |||
12-7374458-T-G | Likely benign (Nov 01, 2022) | |||
12-7374473-C-T | Likely benign (Apr 01, 2024) | |||
12-7374497-G-C | Likely benign (Apr 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD163L1 | protein_coding | protein_coding | ENST00000313599 | 19 | 133213 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.79e-26 | 0.828 | 125236 | 1 | 511 | 125748 | 0.00204 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.23 | 708 | 806 | 0.878 | 0.0000428 | 9493 |
Missense in Polyphen | 258 | 320.44 | 0.80515 | 3923 | ||
Synonymous | 1.96 | 267 | 311 | 0.859 | 0.0000182 | 2803 |
Loss of Function | 2.55 | 52 | 76.0 | 0.685 | 0.00000407 | 837 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00331 | 0.00331 |
Ashkenazi Jewish | 0.00109 | 0.00109 |
East Asian | 0.00181 | 0.00180 |
Finnish | 0.000603 | 0.000601 |
European (Non-Finnish) | 0.00267 | 0.00263 |
Middle Eastern | 0.00181 | 0.00180 |
South Asian | 0.00223 | 0.00219 |
Other | 0.00189 | 0.00147 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.0761
Intolerance Scores
- loftool
- 0.948
- rvis_EVS
- 0.4
- rvis_percentile_EVS
- 76.16
Haploinsufficiency Scores
- pHI
- 0.0527
- hipred
- N
- hipred_score
- 0.163
- ghis
- 0.373
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.136
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- receptor-mediated endocytosis
- Cellular component
- extracellular region;external side of plasma membrane;integral component of membrane
- Molecular function
- scavenger receptor activity